{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:27:16Z","timestamp":1782851236589,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004396","name":"The Thailand Research Fund","doi-asserted-by":"crossref","award":["DPG6280003"],"award-info":[{"award-number":["DPG6280003"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chiang Mai University Research Fund","award":["CMU-2563"],"award-info":[{"award-number":["CMU-2563"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To identify the relationship between quadruple test for aneuploidy screening (alpha-fetoprotein: AFP; free beta-human chorionic gonadotropin: b-hCG; unconjugated estriol: uE3 and inhibin-A: IHA) and fetal growth restriction and to construct predictive models for small-for-gestational-age (SGA) fetuses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Women who underwent quadruple test for aneuploidy were followed-up for final outcomes. The multiples of the median (MoMs) of the four biochemical markers for the SGA group and those of normal fetuses were compared. The models for predicting SGA by the individual biomarkers and their combination were constructed using binary logistic regression analysis, and their diagnostic performances in predicting SGA were determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 10,155 eligible pregnant women, 578 (5.7%) and 9577 (94.3%) had SGA and normal growth, respectively. High levels of AFP, b-hCG and IHA but low levels of uE3 significantly increased the risk of SGA. The constructed predictive equations had predictive performance for SGA, with areas under the receiver-operated characteristic curve of 0.724, 0.655, 0.597, 0.664 and 0.754 for AFP, b-hCG, uE3, IHA, and the combination, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The quad test for aneuploidy screening could also be used as a predictor of SGA, without extra-effort and extra-cost.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-020-03298-9","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T03:02:59Z","timestamp":1602730979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study"],"prefix":"10.1186","volume":"20","author":[{"given":"Rakchanok","family":"Boonpiam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanane","family":"Wanapirak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supatra","family":"Sirichotiyakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratanaporn","family":"Sekararithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0980-2128","authenticated-orcid":false,"given":"Kuntharee","family":"Traisrisilp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theera","family":"Tongsong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"3298_CR1","volume-title":"Williams obstetrics","author":"FG Cunningham","year":"2018","unstructured":"Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, et al. Williams obstetrics. 25th ed. New York: McGraw-Hill Education; 2018.","edition":"25"},{"key":"3298_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1515\/jpm-2016-0101","volume":"45","author":"K Bartkute","year":"2017","unstructured":"Bartkute K, Balsyte D, Wisser J, Kurmanavicius J. Pregnancy outcomes regarding maternal serum AFP value in second trimester screening. J Perinat Med. 2017;45:817\u201320.","journal-title":"J Perinat Med"},{"key":"3298_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5603\/GP.a2017.0061","volume":"88","author":"D Basbug","year":"2017","unstructured":"Basbug D, Basbug A, Gulerman C. Is unexplained elevated maternal serum alpha-fetoprotein still important predictor for adverse pregnancy outcome? Ginekol Pol. 2017;88:325\u201330.","journal-title":"Ginekol Pol"},{"key":"3298_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3109\/01443615.2015.1036400","volume":"36","author":"P Sirikunalai","year":"2016","unstructured":"Sirikunalai P, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Associations between maternal serum free beta human chorionic gonadotropin (beta-hCG) levels and adverse pregnancy outcomes. J Obstet Gynaecol. 2016;36:178\u201382.","journal-title":"J Obstet Gynaecol"},{"key":"3298_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/pd.1251","volume":"25","author":"K Spencer","year":"2005","unstructured":"Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005;25:949\u201353.","journal-title":"Prenat Diagn"},{"key":"3298_CR6","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.3109\/14767058.2015.1075503","volume":"29","author":"T Settiyanan","year":"2016","unstructured":"Settiyanan T, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Association between isolated abnormal levels of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 2016;29:2093\u20137.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3298_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S1701-2163(16)32973-5","volume":"30","author":"A Gagnon","year":"2008","unstructured":"Gagnon A, Wilson RD. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can. 2008;30:918\u201332.","journal-title":"J Obstet Gynaecol Can"},{"key":"3298_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00404-014-3606-9","volume":"292","author":"P Puntachai","year":"2015","unstructured":"Puntachai P, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Associations between pregnancy outcomes and unexplained high and low maternal serum alpha-fetoprotein levels. Arch Gynecol Obstet. 2015;292:81\u20135.","journal-title":"Arch Gynecol Obstet"},{"key":"3298_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000020801","volume":"13","author":"PK Bryant-Greenwood","year":"1998","unstructured":"Bryant-Greenwood PK, O'Brien JE, Huang X, Yaron Y, Ayoub M, Johnson MP, et al. Maternal weight differences do not explain ethnic differences in biochemical screening. Fetal Diagn Ther. 1998;13:46\u20138.","journal-title":"Fetal Diagn Ther"},{"key":"3298_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/pd.4602","volume":"35","author":"S Manotaya","year":"2015","unstructured":"Manotaya S, Zitzler J, Li X, Wibowo N, Pham TM, Kang MS, et al. Effect of ethnicity on first trimester biomarkers for combined trisomy 21 screening: results from a multicenter study in six Asian countries. Prenat Diagn. 2015;35:735\u201340.","journal-title":"Prenat Diagn"},{"key":"3298_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/pd.1153","volume":"25","author":"K Spencer","year":"2005","unstructured":"Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of oriental, Asian and afro-Caribbean populations. Prenat Diagn. 2005;25:365\u20139.","journal-title":"Prenat Diagn"},{"key":"3298_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/(SICI)1097-0223(199608)16:8<691::AID-PD946>3.0.CO;2-2","volume":"16","author":"HC Watt","year":"1996","unstructured":"Watt HC, Wald NJ, Smith D, Kennard A, Densem J. Effect of allowing for ethnic group in prenatal screening for Down\u2019s syndrome. Prenat Diagn. 1996;16:691\u20138.","journal-title":"Prenat Diagn"},{"key":"3298_CR13","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1080\/14767058.2017.1358264","volume":"31","author":"T Lerthiranwong","year":"2018","unstructured":"Lerthiranwong T, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Strong impact of ethnicity on effectiveness of the first trimester maternal serum screen of fetal Down syndrome. J Matern Fetal Neonatal Med. 2018;31:2847\u201351.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3298_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejogrb.2014.07.018","volume":"181","author":"JL Cohen","year":"2014","unstructured":"Cohen JL, Smilen KE, Bianco AT, Moshier EL, Ferrara LA, Stone JL. Predictive value of combined serum biomarkers for adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol. 2014;181:89\u201394.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3298_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0301-2115(03)00081-2","volume":"110","author":"K Duric","year":"2003","unstructured":"Duric K, Skrablin S, Lesin J, Kalafatic D, Kuvacic I, Suchanek E. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. Eur J Obstet Gynecol Reprod Biol. 2003;110:12\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3298_CR16","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1056\/NEJM199912303412701","volume":"341","author":"DL Walton","year":"1999","unstructured":"Walton DL, Norem CT, Schoen EJ, Ray GT, Colby CJ. Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy. N Engl J Med. 1999;341:2033\u20138.","journal-title":"N Engl J Med"},{"key":"3298_CR17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0002-9378(99)70334-0","volume":"181","author":"Y Yaron","year":"1999","unstructured":"Yaron Y, Cherry M, Kramer RL, O'Brien JE, Hallak M, Johnson MP, et al. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol. 1999;181:968\u201374.","journal-title":"Am J Obstet Gynecol"},{"key":"3298_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/M14-0697","volume":"162","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162:55\u201363.","journal-title":"Ann Intern Med"},{"key":"3298_CR19","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.","journal-title":"BMJ"},{"key":"3298_CR20","first-page":"482","volume":"76","author":"T Tongsong","year":"1993","unstructured":"Tongsong T, Simaraks S, Sirivatanapa P, Sudasna J, Wanapirak C, Kunavikatikul C, et al. Study of intrauterine growth from birthweight at Maharaj Nakhon Chiang Mai hospital. J Med Assoc Thail. 1993;76:482\u20136.","journal-title":"J Med Assoc Thail"},{"key":"3298_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/01.AOG.0000172419.37410.eb","volume":"106","author":"L Dugoff","year":"2005","unstructured":"Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005;106:260\u20137.","journal-title":"Obstet Gynecol"},{"key":"3298_CR22","doi-asserted-by":"publisher","first-page":"228.e1","DOI":"10.1016\/j.ajog.2012.06.006","volume":"207","author":"RN Olsen","year":"2012","unstructured":"Olsen RN, Woelkers D, Dunsmoor-Su R, Lacoursiere DY. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia. Am J Obstet Gynecol. 2012;207:228.e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"3298_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1055\/s-2006-947724","volume":"23","author":"AO Odibo","year":"2006","unstructured":"Odibo AO, Sehdev HM, Stamilio DM, Macones GA. Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction. Am J Perinatol. 2006;23:363\u20137.","journal-title":"Am J Perinatol"},{"key":"3298_CR24","first-page":"358","volume":"95","author":"A Mangklabruks","year":"2012","unstructured":"Mangklabruks A, Rerkasem A, Wongthanee A, Rerkasem K, Chiowanich P, Sritara P, et al. The risk factors of low birth weight infants in the northern part of Thailand. J Med Assoc Thail. 2012;95:358\u201365.","journal-title":"J Med Assoc Thail"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03298-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-020-03298-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03298-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T10:57:51Z","timestamp":1634295471000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-03298-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3298"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-03298-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-51253\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-51253\/v2","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Boards; The Research Ethics Committee 4; Faculty of Medicine, Chiang Mai University. Study Code: OBG-2562-06069 \/ Research ID: 06069.All participants were recruited with written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The Informed Consent Forms which all participants signed included consent for publication of their data. Data were de-identified after collection and participants were allocated codes for analysis and pseudonyms for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"621"}}